Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Viral load dynamics in transmissible symptomatic patients with COVID-19

Hitoshi Kawasuji, Yusuke Takegoshi, Makito Kaneda, Akitoshi Ueno, Yuki Miyajima, Koyomi Kawago, Yasutaka Fukui, Yoshihiko Yoshida, Miyuki Kimura, Hiroshi Yamada, Ippei Sakamaki, Hideki Tani, Yoshitomo Morinaga, Yoshihiro Yamamoto
doi: https://doi.org/10.1101/2020.06.02.20120014
Hitoshi Kawasuji
Toyama University Graduate School of Medicine and Pharmaceutical Sciences, Toyama, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yusuke Takegoshi
Toyama University Graduate School of Medicine and Pharmaceutical Sciences, Toyama, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Makito Kaneda
Toyama University Graduate School of Medicine and Pharmaceutical Sciences, Toyama, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Akitoshi Ueno
Toyama University Graduate School of Medicine and Pharmaceutical Sciences, Toyama, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yuki Miyajima
Toyama University Graduate School of Medicine and Pharmaceutical Sciences, Toyama, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Koyomi Kawago
Toyama University Graduate School of Medicine and Pharmaceutical Sciences, Toyama, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yasutaka Fukui
Toyama University Graduate School of Medicine and Pharmaceutical Sciences, Toyama, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yoshihiko Yoshida
Toyama University Graduate School of Medicine and Pharmaceutical Sciences, Toyama, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Miyuki Kimura
Toyama University Graduate School of Medicine and Pharmaceutical Sciences, Toyama, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hiroshi Yamada
Toyama University Graduate School of Medicine and Pharmaceutical Sciences, Toyama, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ippei Sakamaki
Toyama University Graduate School of Medicine and Pharmaceutical Sciences, Toyama, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hideki Tani
Toyama University Graduate School of Medicine and Pharmaceutical Sciences, Toyama, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yoshitomo Morinaga
Toyama University Graduate School of Medicine and Pharmaceutical Sciences, Toyama, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yoshihiro Yamamoto
Toyama University Graduate School of Medicine and Pharmaceutical Sciences, Toyama, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: yamamoto@med.u-toyama.ac.jp
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

To investigate the relationship between viral load and secondary transmission in novel coronavirus disease 2019 (COVID-19), we reviewed epidemiological and clinical data obtained from immunocompetent laboratory-confirmed patients with COVID-19 at Toyama University Hospital. In total, 28 patients were included in the analysis. Median viral load at the initial sample collection was significantly higher in adults than in children and in symptomatic than in asymptomatic patients. Among symptomatic patients, non-linear regression models showed that the estimated viral load at onset was higher in the index (patients who transmitted the disease to at least one other patient) than in the non-index patients (patients who were not the cause of secondary transmission; median [95% confidence interval]: 6.6 [5.2–8.2] vs. 3.1 [1.5–4.8] log copies/μL, respectively). High nasopharyngeal viral loads around onset may contribute to secondary transmission of COVID-19.

Article Summary Line High nasopharyngeal viral load around the onset may contributes to secondary transmission of COVID-19.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Ethical Review Board of University of Toyama (approval number: R2019167)

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

N/A

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted June 04, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Viral load dynamics in transmissible symptomatic patients with COVID-19
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Viral load dynamics in transmissible symptomatic patients with COVID-19
Hitoshi Kawasuji, Yusuke Takegoshi, Makito Kaneda, Akitoshi Ueno, Yuki Miyajima, Koyomi Kawago, Yasutaka Fukui, Yoshihiko Yoshida, Miyuki Kimura, Hiroshi Yamada, Ippei Sakamaki, Hideki Tani, Yoshitomo Morinaga, Yoshihiro Yamamoto
medRxiv 2020.06.02.20120014; doi: https://doi.org/10.1101/2020.06.02.20120014
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Viral load dynamics in transmissible symptomatic patients with COVID-19
Hitoshi Kawasuji, Yusuke Takegoshi, Makito Kaneda, Akitoshi Ueno, Yuki Miyajima, Koyomi Kawago, Yasutaka Fukui, Yoshihiko Yoshida, Miyuki Kimura, Hiroshi Yamada, Ippei Sakamaki, Hideki Tani, Yoshitomo Morinaga, Yoshihiro Yamamoto
medRxiv 2020.06.02.20120014; doi: https://doi.org/10.1101/2020.06.02.20120014

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (271)
  • Allergy and Immunology (559)
  • Anesthesia (135)
  • Cardiovascular Medicine (1778)
  • Dentistry and Oral Medicine (240)
  • Dermatology (173)
  • Emergency Medicine (317)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (662)
  • Epidemiology (10834)
  • Forensic Medicine (8)
  • Gastroenterology (595)
  • Genetic and Genomic Medicine (2968)
  • Geriatric Medicine (289)
  • Health Economics (534)
  • Health Informatics (1938)
  • Health Policy (837)
  • Health Systems and Quality Improvement (747)
  • Hematology (295)
  • HIV/AIDS (634)
  • Infectious Diseases (except HIV/AIDS) (12535)
  • Intensive Care and Critical Care Medicine (697)
  • Medical Education (300)
  • Medical Ethics (89)
  • Nephrology (325)
  • Neurology (2819)
  • Nursing (152)
  • Nutrition (435)
  • Obstetrics and Gynecology (560)
  • Occupational and Environmental Health (600)
  • Oncology (1475)
  • Ophthalmology (444)
  • Orthopedics (172)
  • Otolaryngology (259)
  • Pain Medicine (190)
  • Palliative Medicine (56)
  • Pathology (382)
  • Pediatrics (870)
  • Pharmacology and Therapeutics (368)
  • Primary Care Research (341)
  • Psychiatry and Clinical Psychology (2653)
  • Public and Global Health (5393)
  • Radiology and Imaging (1019)
  • Rehabilitation Medicine and Physical Therapy (599)
  • Respiratory Medicine (729)
  • Rheumatology (330)
  • Sexual and Reproductive Health (294)
  • Sports Medicine (280)
  • Surgery (329)
  • Toxicology (48)
  • Transplantation (151)
  • Urology (127)